Clinical Trial Update: Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety, tolerability, and pharmacokinetics of LHW090 in patients with moderately impaired renal function has completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• LHW090

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Kidney Disease (CKD) | Phase 2 | Status: COMPLETED | Results posted: 2020-02-05